We are live on ! Find out more
MEDP icon

Medpace

592 hedge funds and large institutions have $10.2B invested in Medpace in 2024 Q1 according to their latest regulatory filings, with 88 funds opening new positions, 182 increasing their positions, 245 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

110% more first-time investments, than exits

New positions opened: 88 | Existing positions closed: 42

62% more call options, than puts

Call options by funds: $83M | Put options by funds: $51.1M

30% more capital inflows, than outflows

Capital inflows: $948M | Capital outflows: $729M

9% more funds holding

Funds holding: 543 → 592 (+49)

1.98% more ownership

Funds ownership: 80.23% → 82.21% (+2%)

8% less funds holding in top 10

Funds holding in top 10: 13 → 12 (-1)

26% less repeat investments, than reductions

Existing positions increased: 182 | Existing positions reduced: 245

Holders
592
Holders Change
+49
Holders Change %
+9.02%
% of All Funds
8.5%
Holding in Top 10
12
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-7.69%
% of All Funds
0.17%
New
88
Increased
182
Reduced
245
Closed
42
Calls
$83​M
Puts
$51.1​M
Net Calls
+$31.9​M
Net Calls Change
+$21.3​M

MEDP Hedge Fund Activity: Q1 2024 in Review

592 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q1 2024, worth a combined $10.2B — up 35% from $7.55B a quarter earlier.

Buyers outnumbered sellers: 88 funds opened new MEDP positions and 42 closed out — a net gain of 46 holders — while 182 added to existing stakes and 245 trimmed.

The largest buyer was Findlay Park Partners, opening a new position worth an estimated $78.5M. The largest seller was Boston Trust Walden, cutting an estimated $77.8M.

  • 592 institutional investors held Medpace (MEDP) as of Q1 2024, up from 543 in Q4 2023.
  • Funds reported $10.2B of Medpace stock for Q1 2024, up 35% quarter-over-quarter.
  • 88 funds opened new Medpace positions in Q1 2024 and 42 closed out, a net change of +46 holders.
  • The largest Medpace buyer in Q1 2024 was Findlay Park Partners, an estimated $78.5M added.
  • The largest Medpace seller in Q1 2024 was Boston Trust Walden, an estimated $77.8M sold.

Based on aggregated 13F filings for Q1 2024.